Physician profile
Akshay Gupta
NPI 1780869701
$27,007.41
in general payments reported to CMS, 2019-2025
33 companies · $781 in 2025
The $781 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $3,034 · 2021: $3,049 · 2022: $5,765 · 2023: $3,599 · 2024: $654 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Food and Beverage: $2,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Food and Beverage | $2,284.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,999.31 | 2019-2025 | Farawave, Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| E.R. Squibb & Sons, L.L.C. | $3,181.36 | 2019-2025 | Eliquis |
| Abbott Laboratories | $887.24 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Ensite, Ensite Precision |
| Cvrx, INC. | $792.33 | 2019-2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $776.88 | 2019-2024 | Xarelto |
| Pfizer INC. | $567.32 | 2019-2025 | |
| Medtronic, INC. | $437.96 | 2023-2024 | Pulseselect, Micra, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.24 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $143.39 | 2024 | Qdot Micro Catheter |
| Novartis Pharmaceuticals Corporation | $131.33 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $114.56 | 2019-2024 | Farxiga, Andexxa |
| Merck Sharp & Dohme LLC | $87.16 | 2023-2025 | Winrevair, Verquvo |
| Amgen INC. | $86.08 | 2019-2024 | Repatha |
| Amarin Pharma, INC. | $85.70 | 2020-2021 | |
| Edwards Lifesciences Corporation | $83.35 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $77.30 | 2019 | |
| Vital Connect, INC | $76.30 | 2022-2024 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $59.98 | 2019 | |
| Abiomed | $29.02 | 2025 | |
| Impulse Dynamics (USA) INC. | $28.76 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.05 | 2023 | Jardiance |
| Kestra Medical Technology Services, INC. | $20.47 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.63 | 2024 | Amvuttra |
| Lexicon Pharmaceuticals, INC. | $18.62 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $18.40 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $18.19 | 2025 | Attruby |
| Chiesi USA, INC. | $17.86 | 2025 | Kengreal |
| Kiniksa Pharmaceuticals, Ltd. | $13.50 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $13.42 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.36 | 2019 | |
| Irhythm Technologies, INC. | $13.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.27 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.